Rapid Decarbonisation of Transport IndustryEarly 2023 the EU‘s Copernicus Climate Change Service highlighted the escalating global temperature trend. Consequently, there is an imperative need to decarbonize sectors, especially transportation, which significantly contributes to CO2 emissions. Electric vehicles offer a path towards decarbonization, but the transition is challenged by range anxieties and infrastructural requirements.A potential solution to bridge this transition is bioethanol, which offers rapid decarbonization due to that most gasoline cars on the road today can drive of 100 % bioethanol (E100) after a relatively cheap modification. E100 has also already seen success in Brazil, where its use dominates the market.However, the bioethanol production currently competes with agricultural land which is a blocker for increasing the production. The innovative solution lies in producing bioethanol using cyanobacteria. These require minimal land, positioning them as a viable alternative to traditional bioethanol sources. However, the process of producing bioethanol through cyanobacteria is too expensive at the current state of the art.AXF Energy has further developed and refined the process of producing bioethanol through cyanobacteria, resulting into additional massive cost reductions. We are now planning to set up an evaluation plant in Spain to cultivate cyanobacteria for bioethanol production using this refined process. The aim is to finally produce bioethanol at market prices without encroaching on agricultural land and reducing greenhouse gas emissions by a minimum of 95% relative to gasoline.The success of this approach could enable a global transition to E100 fuel in the transportation sector, including in cars and heavy transportation, akin to Brazil's success, rapidly decarbonizing transportation even before electric vehicles become the norm.

Status: R&DMaking cancer less deadly by developing the best cure for most cases of cancer with the help of the latest biotechnological discoveries.Ambrego's individualized treatment induces cell-cycle arrest targeted only on cancerous cells, allowing the far safer Ambrego treatment to completely replace the conventional chemotherapy. Also, Ambrego's treatment actively destroys cancerous cells. Given as a supplement to conventional chemotherapy, it can turn a palliative chemotherapy treatment into an effective treatment which cures the patient. Suitable for both humans and animals.More info on https://www.ambrego.com/

AllMediaDesk is a global IT company in the media and advertising industry. We support media groups and sales houses with a full 360° software solution that handles all of their needs within one software stack or, if preferred, can be used in a modular way and can be linked to other third-party-systems. Our software can help to generate more inventory to sell, to reduce manual workflows and to support future-proof use of data.Our modern cloud-based software includes an effective media planning and order management system with full cross-media support even between digital and linear channels. Furthermore, the software offers a powerful trafficking / scheduling functionality that drastically reduces manual work as well as guarantees the best results in inventory management. For digital, the software comes with its own ad server stack for Online Video, Display and Online Audio. To address the growing demand of targeted campaigns, our software comes with its own data marketplace as well as Data Management Platform (DMP) to allow best use of own as well as third-party-data. Besides that, AllMediaDesk operates a platform over which advertisers and agencies can automatically plan and book campaigns on various media providers with a click of a button.